Table 1 Baseline characteristics of study participants with type-B acute aortic syndrome.

From: Predictors of hypoxemia in type-B acute aortic syndrome: a retrospective study

 

Total (N = 224)

Hypoxemia (N = 53)

Non-hypoxemia (N = 171)

p value

Age

70.5 ± 13.8

67.3 ± 14.5

71.5 ± 13.5

0.057

Male

140 (62.5)

44 (83.0)

96 (56.1)

< 0.001

Body mass index (kg/m2)

23.4 (21.0–25.9)

24.8 (23.4–27.4)

22.9 (20.5–25.3)

< 0.001

Obesity

74 (33.0)

25 (47.2)

49 (28.7)

0.018

Current smoker

65 (29.0)

22 (41.5)

43 (25.1)

0.022

Hypertension

176 (78.6)

44 (83.0)

132 (77.2)

0.45

Diabetes mellitus

18 (8.0)

3 (5.7)

15 (8.8)

0.77

Dyslipidemia

71 (31.7)

22 (41.5)

49 (28.7)

0.088

Thoracic/abdominal aortic aneurysm

56 (25.0)

11 (20.8)

45 (26.3)

0.47

Medications on admission

Antiplatelet agent

34 (15.2)

5 (9.4)

29 (17.0)

0.27

Anticoagulant

7 (3.1)

2 (3.8)

5 (2.9)

0.67

Antihypertensive treatment

115 (51.3)

24 (45.3)

91 (53.2)

0.35

Vital signs on admission

Systolic blood pressure (mmHg)

160 (145–188)

173 (148–191)

163 (144–184)

0.13

Diastolic blood pressure (mmHg)

85 (74–98)

88 (74–108)

84 (74–96)

0.37

Heart rate (/min)

77 ± 13

78 ± 12

76 ± 14

0.42

Laboratory data on admission

White blood cell (/µL)

9100 (7275–11,625)

9799 (8200–13,200)

8800 (6800–10,800)

1.5 × 10–3

Hemoglobin (g/dL)

13.3 (12.0–14.8)

14.2 (12.7–15.1)

13.2 (11.9–14.4)

0.068

D-dimer (µg/mL)

11.1 (5.8–25.9)

14.5 (6.5–37.2)

6.1 (2.3–13. 8)

< 0.001

Creatinine (mg/dL)

0.82 (0.65–1.12)

1.03 (0.82–1.34)

0.79 (0.63–1.04)

< 0.001

CRP (mg/dL)

0.22 (0.07–0.75)

0.23 (0.08–0.42)

0.22 (0.07–0.82)

0.59

BNP (pg/mL)

39 (19–87)

44.5 (22–74)

37 (19–90)

0.93

CT findings on admission

Patent false lumen

92 (41.1)

33 (62.3)

59 (34.5)

< 0.001

IMH

132 (58.9)

20 (37.7)

112 (65.5)

< 0.001

Maximum aneurysm diameter (mm)

37 (33, 41)

38 (35, 40)

36 (32, 41)

0.14

Pleural effusion

45 (20.1)

15 (28.3)

20 (17.5)

0.12

COPD

34 (15.2)

5 (9.4)

29 (17.0)

0.064

Interstitial pneumonia

4 (1.8)

0 (0.0)

4 (2.3)

0.58

After hospitalization

Minimum PaO2/FiO2 ratio

267 (209–328)

160 (133–175)

305 (246–346)

< 0.001

Timing of hypoxemia (hours)

38 (23, 58)

Peak CRP level (mg/dL)

10.5 (6.8,-5.7)

13.8 (10.5–23.3)

9.1 (6.0–13.1)

< 0.001

Timing of peak CRP level (days)

4 (3, 6)

3 (3, 5)

4 (3, 6)

0.43

ICU stay (days)

5 (3–8)

7 (5–10)

5 (3–7)

< 0.001

Hospital stay (days)

16 (13–22)

20 (14–26)

16 (12.5–21)

0.039

  1. Values are mean ± standard deviation, median (interquartile range), or n (%).
  2. CRP C reactive protein, BNP brain natriuretic peptide, CT computed tomography, IMH intramural hematoma, COPD chronic obstructive pulmonary disease, ICU intensive care unit.